NO985573L - Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporose - Google Patents

Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporose

Info

Publication number
NO985573L
NO985573L NO985573A NO985573A NO985573L NO 985573 L NO985573 L NO 985573L NO 985573 A NO985573 A NO 985573A NO 985573 A NO985573 A NO 985573A NO 985573 L NO985573 L NO 985573L
Authority
NO
Norway
Prior art keywords
osteoporosis
cyclic
growth hormone
coherence
absorbent
Prior art date
Application number
NO985573A
Other languages
English (en)
Other versions
NO985573D0 (no
Inventor
Erik Fink Eriksen
Anne-Marie Kappelgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO985573D0 publication Critical patent/NO985573D0/no
Publication of NO985573L publication Critical patent/NO985573L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ny fremgangsmåte for behandling eller forhindring av utbrudd av osteoporose hos et dyr, f eks et pattedyr, særlig et menneske, som omfatter syklisk administrering til individet av en Veksthormonkomponent eventuelt supplert med kontinuerlig administrering av et medikament med østrogen effekt og/eller et medikament med gestagen effekt.
NO985573A 1996-05-31 1998-11-27 Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporose NO985573L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK62396 1996-05-31
PCT/DK1997/000239 WO1997046252A1 (en) 1996-05-31 1997-05-29 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis

Publications (2)

Publication Number Publication Date
NO985573D0 NO985573D0 (no) 1998-11-27
NO985573L true NO985573L (no) 1999-01-29

Family

ID=8095682

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985573A NO985573L (no) 1996-05-31 1998-11-27 Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporose

Country Status (14)

Country Link
EP (1) EP0907374A1 (no)
JP (1) JP2000512274A (no)
KR (1) KR20000016204A (no)
CN (1) CN1220609A (no)
AU (1) AU3025997A (no)
BR (1) BR9709499A (no)
CA (1) CA2257174A1 (no)
CZ (1) CZ383298A3 (no)
HU (1) HUP9904049A3 (no)
IL (1) IL126983A0 (no)
NO (1) NO985573L (no)
PL (1) PL330239A1 (no)
WO (1) WO1997046252A1 (no)
ZA (1) ZA974785B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
US6784158B1 (en) 1998-06-09 2004-08-31 Novo Nordisk A/S Method for preparing a compound with growth hormone releasing properties
WO1999064456A1 (en) * 1998-06-09 1999-12-16 Novo Nordisk A/S A method for preparing a compound with growth hormone releasing properties
JP2001031635A (ja) * 1999-07-14 2001-02-06 Ajinomoto Co Inc 光学活性ｎ−保護−ｎ−メチル−フェニルアラニン誘導体の製造方法
ATE446758T1 (de) 2000-05-31 2009-11-15 Pfizer Prod Inc Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2602789T3 (es) 2007-02-09 2017-02-22 Ocera Therapeutics, Inc. Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ236618A (en) * 1990-01-03 1997-06-24 Ciba Geigy Ag Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound
JP2557779B2 (ja) * 1990-11-26 1996-11-27 アール． レッカー，ロバート ２成分型骨粗鬆症用薬剤
AU8083694A (en) * 1993-10-19 1995-05-08 Merck & Co., Inc. Combination of bisphosphonates and growth hormone secretagogues

Also Published As

Publication number Publication date
CZ383298A3 (cs) 1999-07-14
JP2000512274A (ja) 2000-09-19
AU3025997A (en) 1998-01-05
HUP9904049A2 (hu) 2000-04-28
HUP9904049A3 (en) 2000-07-28
NO985573D0 (no) 1998-11-27
BR9709499A (pt) 1999-08-10
ZA974785B (en) 1998-01-22
IL126983A0 (en) 1999-09-22
CA2257174A1 (en) 1997-12-11
EP0907374A1 (en) 1999-04-14
KR20000016204A (ko) 2000-03-25
PL330239A1 (en) 1999-05-10
WO1997046252A1 (en) 1997-12-11
CN1220609A (zh) 1999-06-23

Similar Documents

Publication Publication Date Title
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
WO2002041837A3 (en) Treatment of mucositis
FI963036A0 (fi) Munasarjan estrogeenista riippuvaisten tilojen hoito
ITRM910922A0 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e metodo per applicarla.
ATE185971T1 (de) Kombinationspräparat zur behandlung hypogonadaler männer sowie männern mit hypophysenerkrankungen
DK0946151T3 (da) Doseringsform med stigende dosisfrigivelse
DK1153610T3 (da) Matrixproteinpræparater til inflammatoriske og infektiøse tilstande
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
SE9603725D0 (sv) New teatment
GB9103764D0 (en) Compositions
ATE198707T1 (de) Prostaglandinanaloga zur oralen oder vaginalen verabreichung in der routinebehandlung des dritten stadiums der geburtswehen
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
EP0744176A3 (en) Methods for inhibiting bone loss
NO830041L (no) Fremgangsmaate til behandling av azykli hos sauer eller storfe
HUP9802916A2 (hu) Kozmetikai eljárás a bőröregedés jeleinek megelőzésére és kezelésére
IL126983A0 (en) Growth hormone components and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis
Bygdeman et al. Medical termination of early pregnancy: the Swedish experience
NO20010390L (no) Behandling av angstsykdommer
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
TR199801801T2 (xx) Madde k�t�ye kullan�m�n�n tedavisi.
Meyers Effectiveness vs. efficacy of antidepressants for the treatment of late-life depression: introduction to a retrospective chart review of antidepressant use, effectiveness, and adverse effects in adults age 70 and older
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
NO984190L (no) FremgangsmÕte for behandling av insomnia
UA7955A (uk) Спосіб лікування туберкульозу легенів
UA32109A (uk) Спосіб пластики фарингоезофагостоми